SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-133964
Filing Date
2020-12-10
Accepted
2020-12-10 08:30:13
Documents
6
Period of Report
2020-12-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20-37959_18k.htm 8-K 43063
2 EX-3.1 a20-37959_1ex3d1.htm EX-3.1 22951
3 EX-99.1 a20-37959_1ex99d1.htm EX-99.1 11598
4 EX-99.2 a20-37959_1ex99d2.htm EX-99.2 19213
5 GRAPHIC g379591mmi001.jpg GRAPHIC 2434
6 GRAPHIC g379591moi001.jpg GRAPHIC 2249
  Complete submission text file 0001104659-20-133964.txt   104923
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 201379555
SIC: 2834 Pharmaceutical Preparations